0001181431-13-053670.txt : 20131011 0001181431-13-053670.hdr.sgml : 20131011 20131011164603 ACCESSION NUMBER: 0001181431-13-053670 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131009 FILED AS OF DATE: 20131011 DATE AS OF CHANGE: 20131011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MACROGENICS INC CENTRAL INDEX KEY: 0001125345 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 9640 MEDICAL CENTER DRIVE CITY: Rockville STATE: MD ZIP: 20850 BUSINESS PHONE: 301-251-5172 MAIL ADDRESS: STREET 1: 9640 MEDICAL CENTER DRIVE CITY: ROCKVILLE STATE: MD ZIP: 20850 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stewart Stanford John CENTRAL INDEX KEY: 0001587807 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36112 FILM NUMBER: 131148385 MAIL ADDRESS: STREET 1: MACROGENICS, INC. STREET 2: ONE CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 rrd392735.xml FORM 4 X0306 4 2013-10-09 0 0001125345 MACROGENICS INC MGNX 0001587807 Stewart Stanford John C/O MACROGENICS, INC. 9640 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 0 1 0 0 V P, Clinical Oncology Stock Option (right to buy) 16.00 2013-10-09 4 A 0 15979 0 A 2023-10-09 Common Stock 15979 15979 D 12.5% of the option becomes exercisable on April 9, 2014 and the remaining 87.5% vests in 14 substantially equal quarterly installments thereafter. /s/ Lynn Cilinski, attorney-in-fact 2013-10-11